127 related articles for article (PubMed ID: 34976178)
1. LncRNA EIF3J-AS1 functions as an oncogene by regulating MAFG to promote prostate cancer progression.
Ye C; Qin S; Guo F; Yang Y; Wang H; Zhang C; Yang B
J Cancer; 2022; 13(1):146-152. PubMed ID: 34976178
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MAFG-AS1 is involved in human cancer progression.
Li P; Ma X; Gu X
Eur J Med Res; 2023 Nov; 28(1):497. PubMed ID: 37941063
[TBL] [Abstract][Full Text] [Related]
3. MAFG-AS1 aggravates the progression of pancreatic cancer by sponging miR-3196 to boost NFIX.
Ye L; Feng W; Weng H; Yuan C; Liu J; Wang Z
Cancer Cell Int; 2020 Dec; 20(1):591. PubMed ID: 33298078
[TBL] [Abstract][Full Text] [Related]
4. MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression.
Li P; Shi Y; Guo M; Xu H; Zhan M; Wang Z; Chen Y
Front Oncol; 2022; 12():856580. PubMed ID: 35992831
[TBL] [Abstract][Full Text] [Related]
5. EIF3J-AS1 promotes glioma cell growth via up-regulating ANXA11 through sponging miR-1343-3p.
Qi J; Wang Z; Zhao Z; Liu L
Cancer Cell Int; 2020; 20():428. PubMed ID: 32905397
[TBL] [Abstract][Full Text] [Related]
6. H3K27 acetylation-induced lncRNA EIF3J-AS1 improved proliferation and impeded apoptosis of colorectal cancer through miR-3163/YAP1 axis.
Liu D; Zhang H; Cong J; Cui M; Ma M; Zhang F; Sun H; Chen C
J Cell Biochem; 2020 Feb; 121(2):1923-1933. PubMed ID: 31709617
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA MAFG-AS1 promotes proliferation, migration and invasion of hepatocellular carcinoma cells through downregulation of miR-6852.
Ouyang H; Zhang L; Xie Z; Ma S
Exp Ther Med; 2019 Oct; 18(4):2547-2553. PubMed ID: 31572506
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15.
Li H; Zhang GY; Pan CH; Zhang XY; Su XY
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2838-2846. PubMed ID: 31002134
[TBL] [Abstract][Full Text] [Related]
9. A review on the roles and molecular mechanisms of MAFG-AS1 in oncogenesis.
Dabbaghi KG; Mashatan N; Faraz O; Bashkandi AH; Shomoossi N; Tabnak P
Pathol Res Pract; 2023 Mar; 243():154348. PubMed ID: 36736142
[TBL] [Abstract][Full Text] [Related]
10. High-expression of LncRNA MAFG-AS1 is associated with the prognostic of patients with colorectal cancer.
Cui W; Wang Y; Shen X; Wu X; Liu H; Xu X
Rev Assoc Med Bras (1992); 2020 Nov; 66(11):1530-1535. PubMed ID: 33295405
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis.
Sui Y; Lin G; Zheng Y; Huang W
Eur J Pharmacol; 2019 Sep; 859():172465. PubMed ID: 31211984
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4.
Cui S; Yang X; Zhang L; Zhao Y; Yan W
Biochem Biophys Res Commun; 2018 Nov; 506(1):251-258. PubMed ID: 30348529
[TBL] [Abstract][Full Text] [Related]
14. Long Non-coding RNA MAFG-AS1 Promotes Cell Proliferation, Migration, and EMT by miR-3196/STRN4 in Drug-Resistant Cells of Liver Cancer.
Chen T; Huang B; Pan Y
Front Cell Dev Biol; 2021; 9():688603. PubMed ID: 34386494
[TBL] [Abstract][Full Text] [Related]
15. HBx-upregulated MAFG-AS1 promotes cell proliferation and migration of hepatoma cells by enhancing MAFG expression and stabilizing nonmuscle myosin IIA.
Zhang F; Li Y; Gan L; Tong X; Qi D; Wang Q; Ye X
FASEB J; 2021 May; 35(5):e21529. PubMed ID: 33813778
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance.
Feng J; Wen T; Li Z; Feng L; Zhou L; Yang Z; Xu L; Shi S; Hou K; Shen J; Han X; Teng Y
Aging (Albany NY); 2020 Oct; 12(20):20658-20683. PubMed ID: 33098638
[TBL] [Abstract][Full Text] [Related]
17. lncRNA MAFG-AS1 Contributes to Esophageal Squamous-Cell Carcinoma Progression via Regulating miR143/LASP1.
Qu Y; Liu J
Onco Targets Ther; 2020; 13():8359-8370. PubMed ID: 32903907
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA MAFG-AS1 promotes proliferation and metastasis of breast cancer by modulating STC2 pathway.
Di S; Bai R; Lu D; Chen C; Ma T; Zou Z; Zhang Z
Cell Death Discov; 2022 May; 8(1):249. PubMed ID: 35513366
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA MAFG-AS1 knockdown blocks malignant progression in breast cancer cells by inactivating JAK2/STAT3 signaling pathway via MAFG-AS1/miR-3196/TFAP2A axis.
Ding M; Fu Y; Guo F; Chen H; Fu X; Tan W; Zhang H
Int J Clin Exp Pathol; 2020; 13(10):2455-2473. PubMed ID: 33165437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
